| PPP1R15B (CReP) |
|---|
| Full Name | Protein Phosphatase 1 Regulatory Subunit 15B |
| Symbol | PPP1R15B |
| Alias | CReP, Constitutive Repressor of eIF2α Phosphorylation |
| Chromosomal Location | 1q21.3 |
| NCBI Gene ID | 84919 |
| Ensembl ID | ENSG00000167524 |
| UniProt ID | Q9H0X4 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, ALS, Prion disease |
PPP1R15B (also known as CReP, Constitutive Repressor of eIF2α Phosphorylation) is a regulatory subunit of protein phosphatase 1 that dephosphorylates eIF2α. It plays a key role in the integrated stress response (ISR), which is a cellular pathway that coordinates adaptation to various types of stress. CReP is one of two eIF2α phosphatases in mammals (the other being GADD34), and it provides basal repression of the ISR under non-stress conditions. Variants in PPP1R15B have been implicated in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions where endoplasmic reticulum stress and the integrated stress response play important roles in disease pathogenesis.
PPP1R15B encodes CReP (Constitutive Repressor of eIF2α Phosphorylation), a regulatory subunit of protein phosphatase 1 that specifically dephosphorylates eIF2α. This protein is a critical component of the integrated stress response (ISR), which adapts cellular function to various stresses including ER stress, oxidative stress, and amino acid deprivation. Under basal conditions, CReP maintains low levels of eIF2α phosphorylation, allowing normal protein synthesis. Upon stress, eIF2α kinases (PERK, GCN2, PKR, HRI) phosphorylate eIF2α, globally reducing translation while selectively upregulating stress-response genes. CReP then acts as a feedback mechanism to dephosphorylate eIF2α and restore protein synthesis when stress is resolved. Dysregulation of this pathway has been implicated in Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders.
PPP1R15B forms a regulatory subunit complex with protein phosphatase 1 (PP1). This complex specifically targets the alpha subunit of eukaryotic initiation factor 2 (eIF2α):
- CReP protein: 684 amino acids, contains PP1-binding motif
- PP1 catalytic subunit: Provides the phosphatase activity
- Substrate specificity: The CReP regulatory subunit directs PP1 to dephosphorylate specifically eIF2α
The eIF2α phosphatase complex is distinct from the GADD34-containing phosphatase complex, with different regulatory properties and expression patterns.
flowchart TD
A["Stress Stimulus"] --> B["eIF2α Kinases"]
B --> C["PERK (ER stress)"]
B --> D["GCN2 (amino acid deprivation)"]
B --> E["PKR (viral infection)"]
B --> F["HRI (heme deprivation)"]
C --> G["eIF2α Phosphorylation"]
D --> G
E --> G
F --> G
G --> H["Global Translation Inhibition"]
G --> I["ATF4 Translation"]
I --> J["Stress Response Genes"]
H --> K["Reduced Protein Load"]
J --> L["Adaptation & Recovery"]
style A fill:#ffcdd2,stroke:#333
style B fill:#fff3e0,stroke:#333
style C fill:#fff9c4,stroke:#333
style D fill:#fff9c4,stroke:#333
style E fill:#fff9c4,stroke:#333
style F fill:#fff9c4,stroke:#333
style G fill:#f44336,stroke:#333,color:#fff
style H fill:#fff9c4800,stroke:#333
style I fill:#c8e6c9,stroke:#333
style J fill:#c8e6c9,stroke:#333
style K fill:#fff9c4800,stroke:#333
style L fill:#4caf50,stroke:#333
flowchart TD
A["CReP/PP1 Complex"] --> B["eIF2α Dephosphorylation"]
B --> C["Restoration of Translation"]
C --> D["Normal Protein Synthesis"]
D --> E["Cell Survival"]
F["Stress"] --> G["eIF2α Kinase Activation"]
G --> H["eIF2α Phosphorylation"]
H --> I["Global Translation Arrest"]
I --> J["Stress Response Gene Expression"]
H --> K["CReP Feedback Inhibition"]
K --> B
style A fill:#c8e6c9,stroke:#333
style B fill:#c8e6c9,stroke:#333
style C fill:#4caf50,stroke:#333
style D fill:#4caf50,stroke:#333
style E fill:#4caf50,stroke:#333
style F fill:#ffcdd2,stroke:#333
style G fill:#fff9c4,stroke:#333
style H fill:#f44336,stroke:#333,color:#fff
style I fill:#fff9c4800,stroke:#333
style J fill:#c8e6c9,stroke:#333
style K fill:#fff3e0,stroke:#333
CReP plays several critical physiological roles:
- Basal translation control: Maintains normal protein synthesis under non-stress conditions
- Feedback regulation: Controls the duration of the integrated stress response
- ER homeostasis: Helps maintain endoplasmic reticulum function
- Cell survival: Prevents prolonged translation arrest that would lead to apoptosis
- Metabolic regulation: Links nutrient sensing to protein synthesis
- Development: Essential for embryonic development in mice
The integrated stress response is heavily dysregulated in Alzheimer's disease brains:
- eIF2α hyperphosphorylation: Elevated levels of phosphorylated eIF2α in AD brain
- PERK overactivation: The PERK-eIF2α axis is chronically activated in AD
- GADD34 imbalance: Altered ratio of GADD34 to CReP contributes to dysregulation
- Protein synthesis deficits: Reduced global translation may impair synaptic plasticity
The sustained eIF2α phosphorylation in AD may represent a failed attempt at neuroprotection that instead contributes to synaptic dysfunction and memory impairment.
ER stress is a key mechanism in dopaminergic neuron death in Parkinson's disease:
- ER stress in PD: Dopaminergic neurons are particularly vulnerable to ER stress
- CReP protective role: CReP may help protect neurons by reducing eIF2α phosphorylation
- UPR dysregulation: The unfolded protein response is perturbed in PD
- Therapeutic targeting: Modulating eIF2α phosphatases may have therapeutic benefit
- ER stress in ALS: Motor neuron degeneration involves ER stress pathways
- eIF2α signaling: Altered eIF2α phosphorylation in ALS models and patients
- CReP potential: Enhancing CReP activity may protect motor neurons
- eIF2α dysfunction: Prion diseases show profound translation dysregulation
- PERK activation: Early PERK activation in prion disease models
- Therapeutic targeting: eIF2α phosphatases as therapeutic targets
CReP and GADD34 are the two eIF2α phosphatases in mammals with distinct properties:
| Feature |
CReP |
GADD34 |
| Expression |
Constitutive |
Stress-induced |
| Basal activity |
Yes |
Minimal |
| Stress induction |
No |
Strong |
| Knockout phenotype |
Embryonic lethal |
Viable |
flowchart TD
A["Chronic Stress"] --> B["Sustained PERK Activation"]
B --> C["Prolonged eIF2α Phosphorylation"]
C --> D["Sustained Translation Inhibition"]
D --> E["Synaptic Protein Loss"]
D --> F["Memory Protein Deficits"]
E --> G["Synaptic Dysfunction"]
F --> H["Memory Impairment"]
G --> I["Neurodegeneration"]
H --> I
J["Acute Stress"] --> K["Transient eIF2α Phosphorylation"]
K --> L["Adaptive Response"]
L --> M["Cell Survival"]
L --> N["Memory Enhancement"]
style A fill:#ffcdd2,stroke:#333
style B fill:#ffcdd2,stroke:#333
style C fill:#f44336,stroke:#333,color:#fff
style D fill:#fff9c4800,stroke:#333
style E fill:#fff9c4800,stroke:#333
style F fill:#fff9c4800,stroke:#333
style G fill:#f44336,stroke:#333,color:#fff
style H fill:#f44336,stroke:#333,color:#fff
style I fill:#b71c1c,stroke:#333,color:#fff
style J fill:#c8e6c9,stroke:#333
style K fill:#c8e6c9,stroke:#333
style L fill:#4caf50,stroke:#333
style M fill:#4caf50,stroke:#333
style N fill:#4caf50,stroke:#333
¶ ER Stress and Neuronal Vulnerability
The endoplasmic reticulum (ER) is a critical organelle for protein folding, calcium homeostasis, and lipid biosynthesis. Neurons are particularly vulnerable to ER stress due to their high protein synthesis rates, complex morphology, and post-mitotic nature. Several factors contribute to ER stress in neurodegenerative diseases:
-
Accumulation of misfolded proteins: In AD, the accumulation of amyloid-beta and tau leads to ER stress. In PD, alpha-synuclein aggregation causes ER stress. These misfolded proteins trigger the unfolded protein response (UPR).
-
Calcium dysregulation: ER calcium depletion or overload disrupts protein folding capacity. Calcium imbalances activate UPR sensors.
-
Oxidative stress: Reactive oxygen species damage ER proteins and disrupt the redox environment necessary for proper folding.
-
Lipid composition changes: Alterations in membrane lipid composition affect ER function and UPR signaling.
CReP plays a critical role in managing ER stress by maintaining eIF2α phosphorylation levels. When CReP is dysregulated, the adaptive UPR transitions to a pro-apoptotic response.
The PERK-eIF2α-ATF4 pathway is a central component of the integrated stress response that becomes dysregulated in neurodegeneration:
- PERK activation: Upon ER stress, PERK autophosphorylates and activates.
- eIF2α phosphorylation: PERK phosphorylates eIF2α at serine 51.
- ATF4 translation: Phosphorylated eIF2α allows selective translation of ATF4 transcription factor.
- Target gene expression: ATF4 upregulates genes for amino acid metabolism, antioxidant response, and apoptosis.
In chronic neurodegeneration, this pathway becomes persistently activated, leading to:
- Sustained translation repression
- Synaptic protein loss
- Pro-apoptotic gene expression
- Metabolic dysregulation
The integrated stress response directly impacts synaptic function:
- Local translation at synapses: Synapses require local protein synthesis for plasticity. eIF2α phosphorylation inhibits this process.
- Synaptic tagging and capture: Memory consolidation requires protein synthesis at activated synapses. eIF2α phosphorylation impairs this.
- Long-term potentiation (LTP): eIF2α phosphorylation suppresses LTP.
- Memory consolidation: Elevated eIF2α phosphorylation impairs memory formation and consolidation.
CReP is essential for maintaining protein homeostasis in neurons:
- Protein quality control: The UPR attempts to restore ER homeostasis by upregulating chaperones and reducing protein load.
- ER-associated degradation (ERAD): Misfolded proteins are targeted for degradation.
- Autophagy: When ERAD is insufficient, autophagy helps clear damaged proteins.
- Proteostasis failure: In neurodegeneration, these compensatory mechanisms fail, leading to protein aggregate accumulation.
Modulating eIF2α phosphorylation is a promising therapeutic strategy:
| Strategy |
Approach |
Status |
| PERK inhibitors |
Small molecules inhibiting PERK kinase |
Preclinical |
| ISRIB |
eIF2α phosphorylation inhibitor |
Preclinical |
| GADD34 inhibitors |
Reduce eIF2α dephosphorylation |
Research |
| CReP modulators |
Enhance CReP activity |
Research |
- PERK inhibitors: Reduce chronic eIF2α phosphorylation
- ISRIB (Integrated Stress Response Inhibitor): Restores translation despite eIF2α phosphorylation
- Antioxidants: Reduce oxidative stress and ER stress
- Proteostasis modulators: Enhance protein folding capacity
- Viral vector delivery: Target eIF2α phosphatases to specific brain regions
- CRISPR-based editing: Correct pathogenic variants in PPP1R15B
- mRNA delivery: Provide additional CReP expression
| Partner |
Interaction Type |
Function |
| PPP1R15A (GADD34) |
Homolog |
Alternative eIF2α phosphatase |
| PPP1CA |
Catalytic subunit |
Phosphatase activity |
| PPP1R1A |
Regulatory subunit |
PP1 regulatory family |
| eIF2S1 (eIF2α) |
Substrate |
Target of dephosphorylation |
| HSPA5 (BiP) |
Co-chaperone |
ER stress sensing |
| DNAJB11 |
Co-chapterone |
ER folding assistance |
flowchart TD
A["ER Stress"] --> B["UPR Sensors"]
B --> C["PERK"]
B --> D["IRE1"]
B --> E["ATF6"]
C --> F["eIF2α Phosphorylation"]
F --> G["Global Translation Inhibition"]
F --> H["ATF4 Translation"]
G --> I["Pro-Apoptotic Genes"]
H --> J["Adaptive Genes"]
D --> K["XBP1 Splicing"]
K --> L["Chaperone Expression"]
M["CReP/PP1"] --> F
M --> N["eIF2α Dephosphorylation"]
N --> O["Translation Recovery"]
style A fill:#ffcdd2,stroke:#333
style I fill:#f44336,stroke:#333,color:#fff
style O fill:#c8e6c9,stroke:#333
- eIF2α phosphorylation: Can be measured in patient samples
- ATF4 expression: Marker of ISR activation
- ER stress markers: CHOP, BiP levels
- Synaptic proteins: PSD-95, synapsin as markers
- Genetic testing: Identify PPP1R15B variants
- Biomarker panels: ISR activation markers
- Imaging: PET markers of protein aggregation
- Clinical assessment: Cognitive and motor evaluations
- Understanding CReP biology: Elucidate tissue-specific functions
- Therapeutic targeting: Develop selective modulators
- Biomarker development: Identify prognostic markers
- Clinical translation: Advance to clinical trials
- Why are neurons particularly vulnerable to ISR dysregulation?
- How does CReP dysfunction contribute to specific disease features?
- Can ISR modulation prevent neurodegeneration?
- What determines the balance between adaptive and apoptotic UPR?
PPP1R15B is expressed in most tissues with specific patterns:
- Brain: Neurons and glia, particularly in cortex, hippocampus
- Ubiquitous expression: All cell types require basal eIF2α phosphatase activity
- Regulation: Expression is relatively constitutive, not strongly induced by stress
- Subcellular localization: Predominantly cytoplasmic
¶ Genetics and Variants
- Missense variants: Some associated with neurodegenerative disease risk
- Regulatory variants: May affect expression levels
- Splice variants: May alter splicing patterns
Several therapeutic strategies are being explored:
- PERK inhibitors: Reduce eIF2α phosphorylation
- eIF2α phosphatase enhancers: Increase CReP or GADD34 activity
- ISRIB (Integrated Stress Response Inhibitor): Stabilize eIF2α-B ternary complex
- Small molecule correctors: Restore ER homeostasis
- ISRIB: Shows promise in preclinical models
- PERK inhibitors: In clinical development for AD and other diseases
- GADD34 inhibitors: Might be protective in acute stress
- CReP overexpression: Could enhance eIF2α phosphatase activity
- RNAi against GADD34: Shift balance toward CReP activity
- PP1 (Protein Phosphatase 1): Catalytic subunit of the phosphatase complex
- eIF2α: Substrate for dephosphorylation
- ATF4: Transcription factor regulated by eIF2α phosphorylation
- CHOP: Pro-apoptotic transcription factor induced by ER stress
- GADD34: Alternative eIF2α phosphatase (stress-induced)
- Ppp1r15b^-/- mice: Embryonic lethal, demonstrating essential function
- Conditional knockouts: Tissue-specific deletion reveals functions in specific cell types
- CReP overexpression: Protected against ER stress in some models
- CReP deficiency: Exacerbated neurodegeneration in disease models
- Novoa et al., Feedback inhibition of the stress response by the eIF2alpha phosphatase CReP (2001)
- Baird et al., The eIF2alpha stress response pathway in neurodegeneration (2012)
- Ma et al., Dysregulation of the eIF2 alpha kinase PERK and GADD34 in Alzheimer's disease (2013)
- Hoozemans et al., Targeting endoplasmic reticulum stress for neurodegenerative disease therapy (2014)
- Halloran et al., CReP controls eIF2alpha phosphorylation in the integrated stress response (2013)
- Sokka et al., ER stress and unfolded protein response in Parkinson's disease (2019)
- Tseng et al., eIF2alpha phosphorylation as a therapeutic target in Alzheimer's disease (2019)
- Shacham et al., Targeting the eIF2-alpha kinase PERK for neurodegeneration (2019)
- Moylan et al., Integrated stress response in neurodegeneration (2020)
- Kim et al., GADD34 deficiency in neurons promotes neurodegeneration (2019)